Authors: Alyaudtin, RN Reichel, A Lobenberg, R Ramge, P Kreuter, J Begley, DJ

Citation: Rn. Alyaudtin et al., Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brainbarrier in vivo and in vitro, J DRUG TAR, 9(3), 2001, pp. 209

Authors: Lobenberg, R Kramer, J Shah, VP Amidon, GL Dressman, JB

Citation: R. Lobenberg et al., Dissolution testing as a prognostic tool for oral drug absorption: Dissolution behavior of glibenclamide, PHARM RES, 17(4), 2000, pp. 439-444

Authors: Lobenberg, R Amidon, GL Vieira, M

Citation: R. Lobenberg et al., Solubility as a limiting factor to drug absorption, DRUG PHARM, 106, 2000, pp. 137-153

Authors: Araujo, L Lobenberg, R Kreuter, J

Citation: L. Araujo et al., Influence of the surfactant concentration on the body distribution of nanoparticles, J DRUG TAR, 6(5), 1999, pp. 373-385

Authors: Araujo, L Sheppard, M Lobenberg, R Kreuter, J

Citation: L. Araujo et al., Uptake of PMMA nanoparticles from the gastrointestinal tract after oral administration to rats: modification of the body distribution after suspension in surfactant solutions and in oil vehicles, INT J PHARM, 176(2), 1999, pp. 209-224